Jakob Begun

9.1k total citations · 1 hit paper
106 papers, 3.9k citations indexed

About

Jakob Begun is a scholar working on Genetics, Epidemiology and Molecular Biology. According to data from OpenAlex, Jakob Begun has authored 106 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Genetics, 34 papers in Epidemiology and 31 papers in Molecular Biology. Recurrent topics in Jakob Begun's work include Inflammatory Bowel Disease (38 papers), Microscopic Colitis (26 papers) and Gastrointestinal motility and disorders (10 papers). Jakob Begun is often cited by papers focused on Inflammatory Bowel Disease (38 papers), Microscopic Colitis (26 papers) and Gastrointestinal motility and disorders (10 papers). Jakob Begun collaborates with scholars based in Australia, United States and United Kingdom. Jakob Begun's co-authors include Frederick M. Ausubel, Costi D. Sifri, Stephen B. Calderwood, Gary Ruvkun, Danielle A. Garsin, Dennis H. Kim, Ramnik J. Xavier, Páraic Ó Cuív, Timothy H. Florin and Michael A. McGuckin and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Jakob Begun

97 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease

2023 218 citations Édouard Louis, Jakob Begun et al. profile →

Peers

Jakob Begun

GENET

EPIDE

AGING

IMMUN

Fernando Rodrigues Portugal

Ye Wang China

Yi Li China

Cassie L. Behrendt United States

Hisashi Ashida Japan

Shin‐ichi Yokota Japan

Beth A. McCormick United States

Nathaniel Hubert United States

Danping Zheng China

Nobuyuki Kobayashi Japan

Fernando Rodrigues Portugal

Jakob Begun

2.0k ×1.2

251 ×0.3

GENET

1.4k ×1.7

EPIDE

194 ×0.3

AGING

940 ×1.5

IMMUN

Citations per year, relative to Jakob Begun Jakob Begun (= 1×) peers Fernando Rodrigues

Countries citing papers authored by Jakob Begun

Since Specialization

Citations

This map shows the geographic impact of Jakob Begun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakob Begun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakob Begun more than expected).

Fields of papers citing papers by Jakob Begun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jakob Begun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakob Begun. The network helps show where Jakob Begun may publish in the future.

Co-authorship network of co-authors of Jakob Begun

This figure shows the co-authorship network connecting the top 25 collaborators of Jakob Begun. A scholar is included among the top collaborators of Jakob Begun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jakob Begun. Jakob Begun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giri, Rabina, Christopher Altmann, Yenkai Lim, et al.. (2025). Proinflammatory macrophages transporting gut-derived bacterial DNA drive autoimmune arthritis in spondyloarthropathy. JCI Insight. 10(17).

Goodsall, Thomas M, Claire E. Parker, Alice S. Day, et al.. (2025). Editorial: Intestinal Ultrasound for the Assessment of Constipation—Out of the Shadows? Authors' Reply. Alimentary Pharmacology & Therapeutics. 62(8). 855–856.

An, Yoon‐Kyo, et al.. (2025). Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn’s disease. Intestinal Research. 23(4). 475–482. 1 indexed citations

Li, Xaria X., Rabina Giri, Vinod Kumar, et al.. (2025). Colon‐targeted complement C5a₁ receptor inhibition using pH‐sensitive nanoparticles ameliorates experimental colitis. British Journal of Pharmacology. 182(16). 3852–3869. 2 indexed citations

Goodsall, Thomas M, Claire E. Parker, Alice S. Day, et al.. (2025). Expert Position Statement: Defining the Role of Intestinal Ultrasound in Assessing Constipation and Faecal Loading. Alimentary Pharmacology & Therapeutics. 62(8). 799–808. 2 indexed citations

Jones, Graeme, Miriam Calao, Jakob Begun, et al.. (2024). Impact of a Patient Support Program on time to discontinuation of adalimumab in Australian adult patients with immune-mediated inflammatory diseases–an observational study. PLoS ONE. 19(6). e0300624–e0300624.

Lee, Andrew, et al.. (2023). Comprehensive systematic review and pooled analysis of real‐world studies evaluating immunomodulator and biologic therapies for chronic pouchitis treatment. JGH Open. 7(12). 899–907. 1 indexed citations

An, Yoon‐Kyo, Lena Thin, Emily K. Wright, et al.. (2023). P614 Reduction of bowel wall thickness and doppler signals as early as 36 hours predicts corticosteroid response in a multi-centre prospective cohort of Acute Severe Ulcerative Colitis: USUC Study including the GENIUS cohort. Journal of Crohn s and Colitis. 17(Supplement_1). i743–i744. 1 indexed citations

An, Yoon‐Kyo, et al.. (2023). Upadacitinib Salvage Therapy for Infliximab-Experienced Patients with Acute Severe Ulcerative Colitis. Journal of Crohn s and Colitis. 17(12). 2033–2036. 35 indexed citations

10.

Mortlock, Sally, Anton Lord, Grant W. Montgomery, et al.. (2022). An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative Colitis. Journal of Crohn s and Colitis. 17(2). 277–288. 5 indexed citations

11.

Cheon, Jae Hee, Kristine Paridaens, Sameer Al Awadhi, et al.. (2022). The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis. Intestinal Research. 21(1). 161–167. 1 indexed citations

12.

Straube, Jasmin, Katie E. Lineburg, Leanne Cooper, et al.. (2021). Expression of CD49f defines subsets of human regulatory T cells with divergent transcriptional landscape and function that correlate with ulcerative colitis disease activity. Clinical & Translational Immunology. 10(9). e1334–e1334. 4 indexed citations

13.

Dignaß, Axel, Kristine Paridaens, Sameer Al Awadhi, et al.. (2021). Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis. Scandinavian Journal of Gastroenterology. 57(4). 424–431. 5 indexed citations

14.

Sheng, Yonghua, Karen Lawler, Christopher Schmidt, et al.. (2021). IgM and IgA augmented autoantibody signatures improve early‐stage detection of colorectal cancer prior to nodal and distant spread. Clinical & Translational Immunology. 10(9). e1330–e1330. 13 indexed citations

15.

Khor, Bernard, Kara L. Conway, Moshe Biton, et al.. (2019). Distinct Tissue-Specific Roles for the Disease-Associated Autophagy Genes ATG16L2 and ATG16L1. The Journal of Immunology. 203(7). 1820–1829. 19 indexed citations

16.

Sathananthan, Dharshan, et al.. (2019). Gastrointestinal ultrasound in inflammatory bowel disease care: Patient perceptions and impact on disease‐related knowledge. JGH Open. 4(2). 267–272. 42 indexed citations

17.

Cuív, Páraic Ó, Tomás de Wouters, Rabina Giri, et al.. (2017). The gut bacterium and pathobiont Bacteroides vulgatus activates NF-κB in a human gut epithelial cell line in a strain and growth phase dependent manner. Anaerobe. 47. 209–217. 61 indexed citations

18.

Wong, Jennifer A., et al.. (2016). The incidence of 30-day adverse events after colonoscopy in an IBD population. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations

19.

Lourie, Rohan, Hui Tong, V Schreiber, et al.. (2016). High fat diets induce colonic epithelial cell stress and inflammation that is reversed by IL-22. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations

20.

Garsin, Danielle A., Jakob Begun, Dennis H. Kim, et al.. (2003). Long-Lived C. elegans daf-2 Mutants Are Resistant to Bacterial Pathogens. Science. 300(5627). 1921–1921. 465 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact